https://interactions.guidetherapeutiquevih.com/en/interaction-details?id=9784
No pharmaceutical opinion available for this interaction.
Oxcarbazepine can induce the metabolism (CYP 3A4) and decrease the plasma concentration of Elvitegravir / Cobicistat.
Decreased clinical efficacy.
Risk of a possible development of resistance to antiretroviral class.
Monitor for signs and symptoms of therapeutic failure.
–
–
Avoid association. Choose an alternative.
Gabapentin, pregabalin, leviracetam.
–
Viral Load
CD4+
Elvitegravir plasma level
–
–